Literature DB >> 11985495

The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail.

Helen Storey1, Abigail Stewart, Peter Vandenabeele, J Paul Luzio.   

Abstract

It has been reported in some human cells that, in addition to a plasma membrane localization, members of the tumour necrosis factor receptor superfamily may be localized to the Golgi complex. We have shown by immunofluorescence and immunoelectron microscopy that the p55 tumour necrosis factor receptor, TNFR1, is principally localized to the trans-Golgi network in the human breast carcinoma cell line, MCF7. Chimaeras consisting of the extracellular and transmembrane domains of CD8 together with the cytoplasmic tail of TNFR1 were targeted to the trans-Golgi network in stably transfected rat fibroblastic cells. Deletions in the cytoplasmic tails of these chimaeras demonstrated the requirement for the C-terminal sequence of 23 amino acids for this targeting. The 23 amino acid sequence is mostly outside the death domain and contains both an acid patch and a dileucine motif. Interaction of this sequence with membrane traffic adaptor proteins may play an important role in controlling the responses of cells to tumour necrosis factor, since binding of signalling adaptor proteins has only been demonstrated for plasma membrane, and not Golgi-localized, TNFR1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985495      PMCID: PMC1222747          DOI: 10.1042/BJ20020048

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains.

Authors:  F Letourneur; R D Klausner
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

Review 2.  Protein transport from the secretory to the endocytic pathway in mammalian cells.

Authors:  R Le Borgne; B Hoflack
Journal:  Biochim Biophys Acta       Date:  1998-08-14

3.  Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

Authors:  M Bennett; K Macdonald; S W Chan; J P Luzio; R Simari; P Weissberg
Journal:  Science       Date:  1998-10-09       Impact factor: 47.728

4.  Leucine-based receptor sorting motifs are dependent on the spacing relative to the plasma membrane.

Authors:  C Geisler; J Dietrich; B L Nielsen; J Kastrup; J P Lauritsen; N Odum; M D Christensen
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

5.  TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1.

Authors:  S J Jones; E C Ledgerwood; J B Prins; J Galbraith; D R Johnson; J S Pober; J R Bradley
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

6.  Lumenal and transmembrane domains play a role in sorting type I membrane proteins on endocytic pathways.

Authors:  B J Reaves; G Banting; J P Luzio
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

Review 7.  Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis.

Authors:  S S Molloy; E D Anderson; F Jean; G Thomas
Journal:  Trends Cell Biol       Date:  1999-01       Impact factor: 20.808

8.  Association of a phosphatidylinositol-specific 3-kinase with a human trans-Golgi network resident protein.

Authors:  D M Hickinson; J M Lucocq; M C Towler; S Clough; J James; S R James; C P Downes; S Ponnambalam
Journal:  Curr Biol       Date:  1997-12-01       Impact factor: 10.834

9.  Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function.

Authors:  Z Cai; C Capoulade; C Moyret-Lalle; M Amor-Gueret; J Feunteun; A K Larsen; B B Paillerets; S Chouaib
Journal:  Oncogene       Date:  1997-12-04       Impact factor: 9.867

10.  High-affinity binding of the AP-1 adaptor complex to trans-golgi network membranes devoid of mannose 6-phosphate receptors.

Authors:  Y Zhu; L M Traub; S Kornfeld
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

View more
  17 in total

1.  Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.

Authors:  Jennifer S Carew; Steffan T Nawrocki; Yelena V Krupnik; Kenneth Dunner; David J McConkey; Michael J Keating; Peng Huang
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

2.  Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).

Authors:  Adrian A Lobito; Fiona C Kimberley; Jagan R Muppidi; Hirsh Komarow; Adrianna J Jackson; Keith M Hull; Daniel L Kastner; Gavin R Screaton; Richard M Siegel
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

3.  The Membrane-Spanning Peptide and Acidic Cluster Dileucine Sorting Motif of UL138 Are Required To Downregulate MRP1 Drug Transporter Function in Human Cytomegalovirus-Infected Cells.

Authors:  Christopher B Gelbmann; Robert F Kalejta
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

4.  Regulation of Staphylococcus aureus-induced CXCR1 expression via inhibition of receptor mobilization and receptor shedding during dual receptor (TNFR1 and IL-1R) neutralization.

Authors:  Puja Dutta; Sahin Sultana; Rajen Dey; Biswadev Bishayi
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

5.  Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors.

Authors:  Rebecca S Maag; Marie Mancini; Antony Rosen; Carolyn E Machamer
Journal:  Mol Biol Cell       Date:  2005-04-13       Impact factor: 4.138

6.  Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells.

Authors:  Alessio D'Alessio; Martin S Kluger; Jie H Li; Rafia Al-Lamki; John R Bradley; Jordan S Pober
Journal:  J Biol Chem       Date:  2010-05-28       Impact factor: 5.157

7.  Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.

Authors:  Ian Todd; Paul M Radford; Kelly-Ann Draper-Morgan; Richard McIntosh; Susan Bainbridge; Peter Dickinson; Lama Jamhawi; Marios Sansaridis; Mary L Huggins; Patrick J Tighe; Richard J Powell
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

8.  Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression.

Authors:  Ketki M Hatle; Wendy Neveu; Oliver Dienz; Stacia Rymarchyk; Ramiro Barrantes; Sarah Hale; Nicholas Farley; Karen M Lounsbury; Jeffrey P Bond; Douglas Taatjes; Mercedes Rincón
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  Dynamics of RASSF1A/MOAP-1 association with death receptors.

Authors:  Caitlin J Foley; Holly Freedman; Sheryl L Choo; Christina Onyskiw; Nai Yang Fu; Victor C Yu; Jack Tuszynski; Joanne C Pratt; Shairaz Baksh
Journal:  Mol Cell Biol       Date:  2008-05-12       Impact factor: 4.272

10.  Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.

Authors:  J Baillie; D A Sahlender; J H Sinclair
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.